Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma

2 Sept 2022

Abstract excerpt

OBJECTIVE: The authors searched for genetic and transcriptional signatures associated with tumor progression and recurrence in their cohort of patients with meningiomas, combining the analysis of targeted exome, NF2-LOH, transcriptome, and protein expressions. METHODS: The authors included 91 patients who underwent resection of intracranial meningioma at their institution between June 2000 and November 2007. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Meningioma and schwannoma management
Share to Neurofibromatosis and Schwannoma Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36029259
DOI: 10.3171/2022.7.jns22953

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningiomaPMID 36029259Read ↗

Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilitiesSemantic proximity Read ↗

The multiomic landscape of meningiomas: a review and updateSemantic proximity Read ↗

Single-Cell Analysis of Meningiomas Reveals Mutation-Associated Tumor and Immune Cell Gene Expression ProgramsSemantic proximity Read ↗

Meningioma epigenetic grouping reveals biologic drivers and therapeutic vulnerabilitiesSemantic proximity Read ↗

Epigenetic and genomic profiling of chordoid meningioma: implications for clinical managementSemantic proximity Read ↗

Development and validation of a molecular classifier of meningiomasSemantic proximity Read ↗

Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresSemantic proximity Read ↗

A clinically applicable integrative molecular classification of meningiomas.Semantic proximity Read ↗

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasSemantic proximity Read ↗

Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomasSemantic proximity Read ↗

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasSemantic proximity Read ↗

Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical OutcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.